Search - tctmd.com

Displaying 1 - 20 of 3533

Sort: Relevancy | Date

News Conference News AHA 2025

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

Michael O'Riordan

November 12, 2025

News Conference News AHA 2025

Beta-blockers Not Helpful After MI in Patients With Preserved EF

Yael L. Maxwell

November 12, 2025

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

L.A. McKeown

November 04, 2025

News Conference News TCT 2025

AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations

Todd Neale

October 31, 2025

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Conference News TCT 2025

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

Todd Neale

October 28, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

Presentation TCT 2025

AI-Enabled ECG Interpretation in STEMI: Findings from a Multicenter U.S. Registry

Presenter: Timothy D. Henry

October 28, 2025

Presentation TCT 2025

TCT 69: Optimal P2Y12 inhibitor strategy after acute coronary syndrome: a network meta-analysis of randomised controlled trials

Presenter: Yousif Ahmad

October 28, 2025

Presentation TCT 2025

TCT 68: Early Initiation of PCSK9 Inhibitors in Acute STEMI: Safety and Efficacy Outcomes from the EARLY-STEMI Trial

Presenter: Mohammed Ali

October 28, 2025

Presentation TCT 2025

TCT 66: Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction: the DAPA-STEMI Trial

Presenter: Claudio Laudani

October 28, 2025

Presentation TCT 2025

TCT 65: Colchicine for Post-Myocardial Infarction Management: A Systematic Review and Meta-Analysis

Presenter: Aqeel Khanani

October 28, 2025

Presentation TCT 2025

TCT 1952: Medisattva Is a Mobile Application, (First of Its Kind in the World) Which Prevents Medical Prescription Errors

Presenter: Krishnakishore Goyal

October 28, 2025

Presentation TCT 2025

TCT 60: Acute-phase Lipid-lowering Effects of Evolocumab in Patients with AMI; Pre-specified Secondary Analysis of the EVO-STEMI Trial

Presenter: Hyun-Jong Lee

October 28, 2025

Presentation TCT 2025

TCT 59: Evolocumab in Patients with Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation

Presenter: Jinying Zhou

October 28, 2025

Presentation TCT 2025

When and How Should I Use Physiologic Indices in Patients with STEMI or NSTEMI

Presenter: Kayla Chiew

October 28, 2025

Presentation TCT 2025

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

Presenter: Claudio Laudani

October 28, 2025

Presentation TCT 2025

Effects of Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator as an Adjunct to Primary PCI in Patients with STEMI and Large Thrombus Burden: A Randomized, Double-Blind, Placebo-Controlled Trial

Presenter: Shamir R. Mehta

October 28, 2025

Advertisement

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

Beta-blockers Not Helpful After MI in Patients With Preserved EF

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

What’s Going to Be Hot at AHA 2025?

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

AI-Enabled ECG Interpretation in STEMI: Findings from a Multicenter U.S. Registry

TCT 69: Optimal P2Y12 inhibitor strategy after acute coronary syndrome: a network meta-analysis of randomised controlled trials

TCT 68: Early Initiation of PCSK9 Inhibitors in Acute STEMI: Safety and Efficacy Outcomes from the EARLY-STEMI Trial

TCT 66: Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction: the DAPA-STEMI Trial

TCT 65: Colchicine for Post-Myocardial Infarction Management: A Systematic Review and Meta-Analysis

TCT 1952: Medisattva Is a Mobile Application, (First of Its Kind in the World) Which Prevents Medical Prescription Errors

TCT 60: Acute-phase Lipid-lowering Effects of Evolocumab in Patients with AMI; Pre-specified Secondary Analysis of the EVO-STEMI Trial

TCT 59: Evolocumab in Patients with Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation

When and How Should I Use Physiologic Indices in Patients with STEMI or NSTEMI

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

Effects of Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator as an Adjunct to Primary PCI in Patients with STEMI and Large Thrombus Burden: A Randomized, Double-Blind, Placebo-Controlled Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content